LABU Holdings Information

LABU is an equity ETF with a total of 166 individual holdings.

Total Holdings

166

Top 10 Percentage

46.15%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

539.72M

PE Ratio

n/a

Breakdown by Sector

No.	Symbol	Name	% Weight	Shares
1	n/a	Dreyfus Govt Cash Man Ins	17.02%	93,968,860
2	n/a	Goldman Finl Sq Trsry Inst 506	7.43%	41,012,326
3	n/a	Cash	4.59%	25,336,450
4	n/a	S&P Biotechnology Select Industry Index Swap	4.48%	25,717
5	n/a	S&P Biotechnology Select Industry Index Swap	3.28%	35,888
6	n/a	Goldman Sachs Fin Gov 465 Institut	2.71%	14,947,640
7	n/a	S&P Biotechnology Select Industry Index Swap	2.55%	23,421
8	n/a	S&P Biotechnology Select Industry Index Swap	1.60%	10,766
9	TGTX	TG Therapeutics, Inc.	1.26%	145,016
10	n/a	S&P Biotechnology Select Industry Index Swap	1.24%	8,962
11	TVTX	Travere Therapeutics, Inc.	1.22%	137,465
12	ALKS	Alkermes plc	1.19%	146,478
13	TWST	Twist Bioscience Corporation	1.16%	86,800
14	RVMD	Revolution Medicines, Inc.	1.10%	40,844
15	n/a	S&P Biotechnology Select Industry Index Swap	1.02%	6,011
16	EXEL	Exelixis, Inc.	0.94%	97,426
17	ARWR	Arrowhead Pharmaceuticals, Inc.	0.94%	70,006
18	KRYS	Krystal Biotech, Inc.	0.93%	15,953
19	NBIX	Neurocrine Biosciences, Inc.	0.93%	31,398
20	NUVL	Nuvalent, Inc.	0.91%	40,656
21	APGE	Apogee Therapeutics, Inc.	0.88%	54,466
22	INCY	Incyte Corporation	0.84%	42,971
23	PTGX	Protagonist Therapeutics, Inc.	0.84%	42,161
24	PTCT	PTC Therapeutics, Inc.	0.84%	61,937
25	BEAM	Beam Therapeutics Inc.	0.83%	155,969

Showing 25 of 166 holdings

Subscribe to see the full list

As of Jun 11, 2026